Pamela Misajon is Director of Kiromic Biopharma, Inc.. Currently has a direct ownership of 28,811 shares of KRBP, which is worth approximately $25,929. The most recent transaction as insider was on Jun 12, 2024, when has been sold 1,610 shares (Common Stock) at a price of $3.27 per share, resulting in proceeds of $5,264. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.8K
0% 3M change
n/a 12M change
Total Value Held $25,929

Pamela Misajon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Open market or private purchase
$5,264 $3.27 p/Share
1,610 Added 5.29%
28,811 Common Stock
Jun 10 2024
BUY
Open market or private purchase
$4,983 $2.93 p/Share
1,701 Added 5.89%
27,201 Common Stock
Mar 18 2024
BUY
Grant, award, or other acquisition
-
18,000 Added 41.38%
25,500 Restricted Stock Award
PM

Pamela Misajon

Director
Houston, TX

Track Institutional and Insider Activities on KRBP

Follow Kiromic Biopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRBP shares.

Notify only if

Insider Trading

Get notified when an Kiromic Biopharma, Inc. insider buys or sells KRBP shares.

Notify only if

News

Receive news related to Kiromic Biopharma, Inc.

Track Activities on KRBP